Related Experiment Video
Updated: Jun 1, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
HSV serologic testing for pregnant women: willingness to be tested and factors affecting testing
David A Baker1, Andrea Pressley, Lillian Meek
1Division of Infectious Diseases, Department of Obstetrics, Gynecology, and Reproductive Medicine, School of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794-8091, USA. dbaker@notes.cc.sunysb.edu
Objective:
This prospective study was undertaken to evaluate pregnant women's willingness to undergo HSV type-specific serologic testing and factors affecting willingness in an obstetrics/gynecology ambulatory unit.
Methods:
At prenatal Visit 1, pregnant women (n = 303) with no history of HSV-2 were tested for HSV-1/HSV-2 before and after they received counseling on genital and neonatal herpes.
Results:
In both the Unwilling Subgroup and the group that changed from being willing to being unwilling, the most common reasons for choosing not to be tested were not being at risk for genital herpes, being tested is too personal, and concern about what will be done with the results. Of the 134 participants in the Willing/Tested Subgroup, 27 (20%) were HSV-2 seropositive and 81 (60%) were HSV-1 seropositive. Conclusions. These results support the feasibility of HSV serologic testing and counseling in pregnant women.
Related Concept Videos
Genital Herpes
Herpes
Cytomegalovirus Disease
Rh Blood Group